Liver4Life

Liver4Life is a Swiss biotechnology and medical device company focused on revolutionizing liver transplantation through advanced ex vivo organ perfusion. Originating as a multidisciplinary project at Wyss Zurich, the company has developed a proprietary perfusion system that mimics human physiology to sustain livers outside the body for up to seven days. This technology significantly extends the traditional 12-hour preservation limit, allowing for the assessment, repair, and regeneration of marginal donor organs that would otherwise be discarded. In 2022, the Liver4Life team achieved a landmark clinical success by performing the first human liver transplant using an organ preserved for three days. The company's platform aims to alleviate the global organ shortage and improve outcomes for patients with end-stage liver disease. Beyond preservation, the technology offers a unique window for therapeutic interventions, such as oncology treatments or gene therapy, performed directly on the isolated organ.